Significance of Various Enzymes in the Control of Mutagenic and Carcinogenic Metabolites Derived from Aromatic Structures

Abstract

One important early contribution to the control of chemical carcinogenesis is provided by the enzyme pattern responsible for the generation and disposition of reactive metabolites. Especially well studied is the important group of enzymes responsible for the control of reactive epoxides. Many natural as well as man-made foreign compounds, including Pharmaceuticals, possess olefinic or aromatic double bonds. Such compounds can be transformed to epoxides by microsomal monooxygenases present in very many mammalian organs. By virtue of their electrophilic reactivity such epoxides may spontaneously react with nucleophilic centers in the cell and thus covalently bind to DNA, RNA, and protein. Such alterations of critical cellular macromolecules may disturb the normal biochemistry of the cell and lead to cytotoxic, allergenic, mutagenic, and/or carcinogenic effects. Whether such effects will be manifested depends on one hand on the chemical reactivity as well as other properties (geometry, lipophilicity) of the epoxide in question. On the other hand, enzymes controlling the concentration of such epoxides are another important contributing factor. Several microsomal monooxygenases exist differing in activity and substrate specificity. With respect to large substrates, some monooxygenases preferentially attack at one specific site different from that attacked by others. Some of these pathways lead to reactive products, others are detoxification pathways. Moreover, enzymes metabolizing such epoxides represent a further determining factor. These enzymes include epoxide hydrolases and glutathione transferases. These enzymes do not play a pure inactivating role, but can in some cases also act as coactivating enzymes. Enzymes involved in biosynthesis and further metabolism of epoxides differ in quantity and sometimes also in substrate specificity between organs, developmental stages, sexes, and animal species. They therefore represent one important contributing factor to differences in susceptibilities between species and individuals.

References

1. Arias IM and Jakoby WB (1976). Glutathione: metabolism and function. Kroc Found Ser. 6.

2. Bentley P and Oesch F (1975). Purification of rat liver epoxide hydratase to apparent homogeneity. FEBS Lett. 59: 291–295.

3. Bentley P , Oesch F , and Glatt HR (1977). Dual role of epoxide hydratase in both activation and inactivation. Arch. Toxicol. 39: 65–75.

4. Bentley P , Schmassmann HU , Sims P , and Oesch F (1976). Epoxides derived from various polycyclic hydrocarbons as substrates of homogeneous and microsome-bound epoxide hydratase: A general assay and kinetic properties. Eur. J. Biochem. 69: 97–103.

5. Booth J , Hewer A , Keysell GR , and Sims P (1975). Enzymatic reduction of aromatic hydrocarbon epoxides by the microsomal fraction of rat liver. Xenobiotica 5: 197–203.

6. Cooper CS , MacNicoll AD , Ribeiro O. Gervasi GP , Hewer A , Walsh C , Pal K , Grover PL , and Sims P (1980). The involvement of a non-“bay-region” diol epoxide in the metabolic activation of benzo(a)anthracene in hamster embryo cells. Cancer Lett 9: 53–59.

7. Friedberg T , Milbert U , Bentley P , Guenthner TM , and Oesch F (1983). Purification and characterization of a new cytosolic glutathione S-transferase (glutathione S-trasnferase X) from rat liver. Biochem. J. 215: 617–625.

8. Glatt HR , Billings R , Platt KL , and Oesch F (1981). Improvement of the correlation of bacterial mutagenicity with carcinogenicity of benzo(a)pyrene and four of its major metabolites by activation with intact liver cells instead of cell homogenate. Cancer Res. 41: 270–277.

9. Glatt HR , Cooper CS , Grover PL , Sims P , Bentley P , Merdes M , Waechter F , Vogel K , Guenthner TM , and Oesch F (1982). Inactivation of a diol epoxide by dihydrodiol dehydrogenase but not by two epoxide hydrolases. Science 215: 1507–1509.

10.

10. Glatt HR , Friedberg T , Grover PL , Sims P , and Oesch F (1983). Inactivation of a diol epoxide and a K region epoxide with high efficiency by glutathione transferase X. Cancer Res. 43: 5713–5717.

11.

11. Glatt HR and Oesch F (1977). Inactivation of electrophilic metabolites by glutathione transferases and limitation of the system due to subcellular localization. Arch. Toxicol. 39: 87–96.

12.

12. Glatt HR , Vogel K. Bentley P , and Oesch F (1979). Reduction of benzo(a)pyrene mutagenicity by dihydrodiol dehydrogenase. Nature 277: 319–320.

13.

13. Guenthner T and Oesch F (1981). Microsomal epoxide hydrolase and its role in polycyclic aromatic hydrocarbon biotransformation. In: Polycyclic Hydrocarbons and Cancer, H. Gelboin and POP Ts'o (eds). Academic Press, New York, Vol. 3, pp. 183–212.

14.

14. Guenthner TM , Jernström B , and Orrenius S (1980). On the effect of cellular nucleophiles on the binding of metabolites of 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene and 9-hydroxy-benzo(a)pyrene to nuclear DNA. Carcinogenesis 1: 407–418.

15.

15. Huberman E , Sachs L , Yang SK , and Gelboin HV (1976). Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells. Proc. Natl. Acad. Sci. 73: 607–611.

16.

16. Jacoby WB , Ketley JN , and Habig WH (1976). Rat glutathiono S-transferases: Binding and physical properties. In: Glutathione: Metabolism and Function, JM Arias and WB Jacoby (eds). Raven Press, New York. Vol. 6, pp. 213–223.

17.

17. Jerina DM and Daly JW (1974). Arene oxides: A new aspect of drug metabolism. Science 185: 573–582.

18.

18. Jerina DM , Dansette PM , Lu AYH , and Levin W (1977). Hepatic microsomal epoxide hydrolase: a sensitive radiometric assay for hydration of arene oxides of carcinogenic aromatic hydrocarbons. Mol. Pharmacol. 13: 342–351.

19.

19. Kapitulnik J , Wislocki PG , Levin W , Yagi H , Jerina DM , and Conney AH (1978). Tumorigenic studies with diol epoxides of benzo(a)pyrene which indicate that (+)-trans-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice. Cancer Res. 38: 354.

20.

20. Lehr RE and Jerina DM (1977). Metabolic activations of polycyclic hydrocarbons. Arch. Toxicol. 39: 1–6.

21.

21. MacNicoll AD , Cooper CS , Ribeiro O , Pal K , Hewer A , Grover PL , and Sims P (1981). The metabolic activation of benzo(a)anthracene in three biological systems. Cancer Lett. 11: 243–249.

22.

22. Malaveille C , Kuroki T , Sims P , Grover PL , and Bartsch H (1977). Mutagenicity of isomeric diol epoxides of benzo(a)pyrene and benzo(a)anthracene in Salmonella typhimurium TA98 and TA100 and in V79 Chinese hamster cells. Mutat. Res. 44: 313–326.

23.

23. Miller EC and Miller JA (1973). Biochemical mechanisms of chemical carcinogens. In: The Molecular Biology of Cancer, H Busch (ed). Academic Press, New York, pp. 377–402.

24.

24. Nebert DVV , Robinson JR , Niwa A , Kumaki K , and Poland AP (1975). Genetic expression of aryl hydrocarbon hydroxylase activity in the mouse. J. Cell. Physiol. 85: 393–414.

25.

25. Newbold RF and Brookes P (1976). Exceptional mutagenicity of benzo(a)pyrene diol epoxide in cultured mammalian cells. Nature 261: 52–54.

26.

26. Oesch F (1973). Mammalian epoxide hydrases: Inducible enzymes catalyzing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds. Xenobiotica 3: 305–340.

27.

27. Oesch F (1976). Differential control of rat microsomal ‘aryl hydrocarbon’ monooxygenase and epoxide hydratase. J. Biol. Chem. 251: 79–87.

28.

28. Oesch F and Glatt HR (1976). Evaluation of the relative importance of various enzymes involved in the control of mutagenic and cytotoxic metabolites. IARC Sci. Pub. 12: 255–274.

29.

29. Sims P and Grover PL (1974). Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis. Adv. Cancer Res. 20: 165–274.

30.

30. Sims P , Grover PL , Swaisland A , Pal K , and Hewer A (1974). Metabolic activation of benzo(a)pyrene proceeds by a diol epoxide. Nature 252: 326–328.

31.

31. Slaga TJ , Bracken WJ , Gleason G , Levin W , Yagi H , Jerina DM , and Conney AH (1979). Marked differences in the skin tumor initiating activities of the optical enantiomers of the diastereometric benzo(a)pyrene 7,8-diol 9,10-epoxides. Cancer Res. 39: 67–71.

32.

32. Snyder R , Parke DV , Kocsis JJ , Jollow DJ , Gibson CG , and Witmer CM (1982). Biological Reactive Intermediates. Plenum Press, New York.

33.

33. Sugiura M , Yamazoe Y , Kamataki T , and Kato R (1980). Reduction of epoxy derivatives of benzo(a)pyrene by microsomal cytochrome P-450. Cancer Res. 40: 2910–2914.

34.

34. Vogel K , Bentley P , Platt KL , and Oesch F (1980). Rat liver cytoplasmic dihydrodiol dehydrogenase: purification to apparent homogeneity and properties. J. Biol. Chem. 255: 9621–9625.

35.

35. Walker CH , Bentley P , and Oesch F (1978). Phylogenetic distribution of epoxide hydratase in different vertebrate species, strains, and tissues measured using three substrates. Biochim. Biophys. Acta 539: 427–434.

36.

36. Wood AW , Chang RL , Levin W , Lehr RE , Schaefer-Ridder M , Karle JM , Jerina DM , and Conney AH (1977). Mutagenicity and cytotoxicity of benzo(a)anthracene diol epoxides and tetrahydro-epoxides: exceptional activity of the bay region 1,2-epoxides. Proc. Natl. Acad. Sci. U. S. A. 74: 2746–2750.

37.

37. Wood AW , Levin W , Lu AYH , Yagi H , Hernandez O , Jerina DM , and Conney AH (1976). Metabolism of benzo(a)pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes. J. Biol. Chem. 251: 4882–4890.